Mechanistic analyses of a novel RNA polymerase I transcription checkpoint
新型RNA聚合酶I转录检查点的机制分析
基本信息
- 批准号:9979913
- 负责人:
- 金额:$ 47.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAnabolismAnimal ModelBiochemicalBiogenesisBiological AssayBiologyCatalytic DomainCell ProliferationCell SurvivalCell modelCellsCellular biologyChemicalsChromatin Remodeling FactorClinicalComplexDNADNA-Directed RNA PolymeraseDataDevelopmentDevelopmental BiologyDiseaseEnsureEnzymesEpigenetic ProcessEquilibriumEukaryotic CellFoundationsFutureGene ExpressionGene-ModifiedGenetic TranscriptionGenomicsGoalsGrowthHealthHistone AcetylationHumanKnowledgeLearningMalignant NeoplasmsMammalian CellMammalsMediatingMolecularMonitorNuclearOncogenicPharmacologyPolymerasePredispositionProcessPropertyProteolysisRNARNA Polymerase IRNA interference screenRecombinant DNARegulationRibosomal DNARibosomal RNARibosomesRoleSignal TransductionSpecific qualifier valueStressSystemTestingTherapeuticTherapeutic InterventionTranscription ElongationTranscription InitiationTranscriptional RegulationTreatment EfficacyUbiquitinUbiquitin-mediated Proteolysis PathwayWorkYeastsbasecancer cellcancer therapycell growthepigenetic druggenome wide screengenome-widehistone methylationhuman diseaseinhibitor/antagonistinsightmammalian genomemulticatalytic endopeptidase complexnew therapeutic targetnovelpre-clinicalresponsesmall moleculetargeted treatmenttherapeutic targettoolubiquitin-protein ligaseyeast genome
项目摘要
ABSTRACT
The growth and proliferation rates of cells are proportional to the rate of ribosome biosynthesis. This
relationship is emphasized in cancer, where the continuous demand for ribosome synthesis is
prevalent. The first step in ribosome biosynthesis is the transcription of the ribosomal (r) DNA by RNA
polymerase I (Pol I); in cancers, this process is deregulated. Despite these established connections
between ribosome biosynthesis and cancer cell proliferation, the regulatory networks that control
transcription elongation at the rDNA locus remain poorly defined.
We have discovered a new regulatory checkpoint that monitors transcription perturbations at the rDNA
and is resolved by the degradation of the Pol I catalytic subunit RPA194. This checkpoint is activated
by our newly identified chemical inhibitor of Pol I (BMH-21). The goal of this application is to
characterize this checkpoint by defining factors and molecular mechanism(s) by which it is activated.
Furthermore, this work will identify the molecular basis for the degradation of the enzyme, and the
reciprocal regulation of the Pols I and II at the rDNA locus.
This proposal will pursue three primary goals: (1) Characterize factors that monitor Pol I elongation;
(2) Define how the Pol I elongation checkpoint is activated and enforced and how it impacts Pol II; and
(3) Identify ubiquitin-proteasome system components that mediate the degradation of RPA194. To
achieve these goals, we will pursue three specific aims. In these aims, BMH-21 and other epigenetic
drugs will be used as tools to study the polymerase-selective checkpoint. Aim 1 characterizes factors
identified in yeast and mammalian genome-wide screens and specifies how they regulate Pol I
transcription. Aim 2 implements biochemically defined transcription assays and genomic analyses to
identify how Pol I transcription perturbations activate the checkpoint, and its impact on polymerase
selectivity. Aim 3 defines the roles of ubiquitin-proteasome system factors in controlling the stability
and transcription of Pol I. In all, these studies provide unprecedented insight into the regulation of Pol I
transcription and the reorganization of nuclear transcription upon inactivation of Pol I. An in-depth,
mechanistic understanding of Pol I transcription regulation will support strategies seeking therapeutic
control of deregulated rRNA synthesis in human disease.
抽象的
细胞的生长和增殖速率与核糖体生物合成速率成正比。这
在癌症中强调关系,核糖体合成的持续需求是
流行。核糖体生物合成的第一步是RNA的核糖体(R)DNA的转录
聚合酶I(pol I);在癌症中,此过程被放松。尽管有这些建立的联系
在核糖体生物合成和癌细胞增殖之间,控制的调节网络
rDNA基因座的转录伸长率仍然很差。
我们发现了一个新的调节检查站,该检查点可以监视rDNA的转录扰动
并通过催化亚基RPA194的降解来解决。此检查点已激活
通过我们新鉴定的Pol I(BMH-21)的化学抑制剂。该应用的目的是
通过定义因子和激活其激活的分子机制来表征此检查点。
此外,这项工作将确定酶降解的分子基础,以及
rDNA基因座的POLS I和II的相互调节。
该建议将实现三个主要目标:(1)表征监测pol I伸长的因素;
(2)定义如何激活和强制激活和强制执行pol I的检查点以及如何影响Pol II;和
(3)确定介导RPA194降解的泛素 - 蛋白酶体系统组件。到
实现这些目标,我们将追求三个具体目标。在这些目标中,BMH-21和其他表观遗传学
药物将用作研究聚合酶选择性检查点的工具。 AIM 1特征因素
在酵母和哺乳动物全基因组筛查中鉴定出来,并指定它们如何调节pol I
转录。 AIM 2实施生化定义的转录测定法和基因组分析
确定pol I转录扰动如何激活检查点及其对聚合酶的影响
选择性。 AIM 3定义了泛素 - 蛋白酶体系统因素控制稳定性的作用
和PolI的转录。在所有这些研究中,这些研究提供了对Pol I的调节的前所未有的见解
转录和核转录的重组。
对POL I转录法规的机械理解将支持寻求治疗的策略
控制人类疾病中失调的rRNA合成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marikki Laiho其他文献
Marikki Laiho的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marikki Laiho', 18)}}的其他基金
Mechanistic analyses of a novel RNA polymerase I transcription checkpoint
新型RNA聚合酶I转录检查点的机制分析
- 批准号:
9381702 - 财政年份:2017
- 资助金额:
$ 47.95万 - 项目类别:
Chemogenomic Profiling of a Novel RNA Polymerase I Inhibitor
新型 RNA 聚合酶 I 抑制剂的化学基因组分析
- 批准号:
9190326 - 财政年份:2016
- 资助金额:
$ 47.95万 - 项目类别:
Dual High-Throughput Imaging Screen for Nucleolar Integrity and RNA Transcription
用于核仁完整性和 RNA 转录的双重高通量成像筛选
- 批准号:
8628965 - 财政年份:2014
- 资助金额:
$ 47.95万 - 项目类别:
Dual High-Throughput Imaging Screen for Nucleolar Integrity and RNA Transcription
用于核仁完整性和 RNA 转录的双重高通量成像筛选
- 批准号:
8786874 - 财政年份:2014
- 资助金额:
$ 47.95万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 47.95万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 47.95万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 47.95万 - 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 47.95万 - 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 47.95万 - 项目类别: